These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38013436)

  • 41. Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.
    Liu X; Huang Y; Cheng M; Pan L; Si Y; Li G; Niu Y; Zhao L; Zhao J; Li X; Chen Y; Yang W
    J Virol; 2013 Feb; 87(3):1649-57. PubMed ID: 23175359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isopeptide Bond Bundling Superhelix for Designing Antivirals against Enveloped Viruses with Class I Fusion Proteins: A Review.
    Na H; Liang G; Lai W
    Curr Pharm Biotechnol; 2023; 24(14):1774-1783. PubMed ID: 37005549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Animal venoms as a source of antiviral peptides active against arboviruses: a systematic review.
    Lima WG; Maia CQ; de Carvalho TS; Leite GO; Brito JCM; Godói IPD; de Lima ME; Ferreira JMS
    Arch Virol; 2022 Sep; 167(9):1763-1772. PubMed ID: 35723756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemically modified antiviral peptides against SARS-CoV-2.
    Quagliata M; Papini AM; Rovero P
    J Pept Sci; 2024 Feb; 30(2):e3541. PubMed ID: 37699615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of
    Jackson JW; Hancock TJ; Dogra P; Patel R; Arav-Boger R; Williams AD; Kennel SJ; Wall JS; Sparer TE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of influenza A virus infection in vitro by peptides designed in silico.
    López-Martínez R; Ramírez-Salinas GL; Correa-Basurto J; Barrón BL
    PLoS One; 2013; 8(10):e76876. PubMed ID: 24146939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DRAVP: A Comprehensive Database of Antiviral Peptides and Proteins.
    Liu Y; Zhu Y; Sun X; Ma T; Lao X; Zheng H
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.
    Sala A; Ardizzoni A; Ciociola T; Magliani W; Conti S; Blasi E; Cermelli C
    Intervirology; 2018; 61(4):166-173. PubMed ID: 30654366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hijacking of host cellular components as proviral factors by plant-infecting viruses.
    Hyodo K; Okuno T
    Adv Virus Res; 2020; 107():37-86. PubMed ID: 32711734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection.
    Lee SM; Yen HL
    Antiviral Res; 2012 Dec; 96(3):391-404. PubMed ID: 23022351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kaempferol: A Review of Current Evidence of Its Antiviral Potential.
    Periferakis A; Periferakis AT; Troumpata L; Periferakis K; Scheau AE; Savulescu-Fiedler I; Caruntu A; Badarau IA; Caruntu C; Scheau C
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro.
    Hong W; Lang Y; Li T; Zeng Z; Song Y; Wu Y; Li W; Cao Z
    J Biol Chem; 2015 Sep; 290(38):23254-63. PubMed ID: 26251517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insects antiviral and anticancer peptides: new leads for the future?
    Slocinska M; Marciniak P; Rosinski G
    Protein Pept Lett; 2008; 15(6):578-85. PubMed ID: 18680452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity.
    Wang L; Sola I; Enjuanes L; Zuñiga S
    mBio; 2021 Oct; 12(5):e0131621. PubMed ID: 34517762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
    Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
    Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding.
    Yu J; Dai Y; Fu Y; Wang K; Yang Y; Li M; Xu W; Wei L
    Antiviral Res; 2021 Mar; 187():105021. PubMed ID: 33508330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short Peptides Make a Big Difference: The Role of Botany-Derived AMPs in Disease Control and Protection of Human Health.
    Luo X; Wu W; Feng L; Treves H; Ren M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway.
    Pattabhi S; Wilkins CR; Dong R; Knoll ML; Posakony J; Kaiser S; Mire CE; Wang ML; Ireton RC; Geisbert TW; Bedard KM; Iadonato SP; Loo YM; Gale M
    J Virol; 2015 Dec; 90(5):2372-87. PubMed ID: 26676770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiviral activity of influenza virus M1 zinc finger peptides.
    Nasser EH; Judd AK; Sanchez A; Anastasiou D; Bucher DJ
    J Virol; 1996 Dec; 70(12):8639-44. PubMed ID: 8970989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human Antimicrobial Peptides as Therapeutics for Viral Infections.
    Ahmed A; Siman-Tov G; Hall G; Bhalla N; Narayanan A
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31374901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.